PABPC1-induced Stabilization of IFI27 MRNA Promotes Angiogenesis and Malignant Progression in Esophageal Squamous Cell Carcinoma Through Exosomal MiRNA-21-5p

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2022 Mar 29

PMID 35346324

Authors

Ying Zhang

Chuangzhen Chen

Zhaoyong Liu

Huancheng Guo

Weiqing Lu

Wang Hu

Zhixiong Lin

Affiliations

Soon will be listed here.

Abstract

Background: Emerging evidence has demonstrated that RNA-binding protein dysregulation is involved in esophageal squamous cell carcinoma (ESCC) progression. However, the role of poly (A) binding protein cytoplasmic 1 (PABPC1) in ESCC is unclear. We therefore aimed to explore the functions and potential mechanisms of PABPC1 in ESCC progression.

Methods: PABPC1 expression was characterized using immunohistochemistry and qRT-PCR in ESCC tissues and cell lines. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays were used to detect histone acetylation in the promoter region of PABPC1. A series of in vitro and in vivo assays were further applied to elucidate the functions and underlying molecular mechanisms of PABPC1 in ESCC angiogenesis and malignant procession.

Results: PABPC1 expression was upregulated in ESCC tissues compared with in normal esophageal epithelial tissues. Elevated PABPC1 expression was correlated with tumor cell differentiation and poor prognosis in patients. Sp1 and p300 cooperated to increase the level of H2K37ac in the PABPC1 promoter. Functionally, PABPC1 overexpression enhanced esophageal squamous cell proliferation and invasion by activating the IFN/IFI27 signaling pathway. PABPC1 interacted with eIF4G to increase the stability of IFI27 mRNA by competing with RNA exosomes in ESCC. Furthermore, PABPC1/IFI27 could increase miR-21-5p expression to enable exosomal delivery of miR-21-5p to human umbilical vein endothelial cells to increase angiogenesis via inhibiting CXCL10.

Conclusion: PABPC1 plays a critical role in ESCC malignant progression by interacting with eIF4G to regulate IFI27 mRNA stability and promote angiogenesis via exosomal miR-21-5p/CXCL10. Taken together, our results suggest that PABPC1 is a promising therapeutic target for ESCC.

Citing Articles

circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLC.

Chen W, Zhao W, Wu X, Fang T, Chen Z, Chen Z Cancer Med. 2025; 14(5):e70729.

PMID: 40013670 PMC: 11866311. DOI: 10.1002/cam4.70729.

HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18-Mediated IFI27 Deubiquitination.

Wang Q, Ren S, Pan Z, Chen Y, Liu X Thorac Cancer. 2025; 16(4):e70013.

PMID: 39993992 PMC: 11850195. DOI: 10.1111/1759-7714.70013.

Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications.

He Z, Ji Y, Yuan Y, Liang T, Liu C, Jiao Y Front Pharmacol. 2025; 16:1532558.

PMID: 39944625 PMC: 11814179. DOI: 10.3389/fphar.2025.1532558.

Exosomes in esophageal cancer: a promising frontier for liquid biopsy in diagnosis and therapeutic monitoring.

Zihan R, Jingsi C, Lingwen D, Xin L, Yan Z Front Pharmacol. 2025; 15:1459938.

PMID: 39741631 PMC: 11685219. DOI: 10.3389/fphar.2024.1459938.

Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases.

Guo W, Zhou B, Dou L, Guo L, Li Y, Qin J Exp Mol Med. 2024; 57(1):59-71.

PMID: 39741182 PMC: 11799171. DOI: 10.1038/s12276-024-01369-x.

References

Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R . The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep. 2016; 17(3):799-808. DOI: 10.1016/j.celrep.2016.09.031. View

He Q, Ye A, Ye W, Liao X, Qin G, Xu Y . Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis. 2021; 12(6):576. PMC: 8178321. DOI: 10.1038/s41419-021-03803-8. View

Si Y, Liu F, Wang D, Fang C, Tang X, Guo B . Exosomal Transfer of miR-185 Is Controlled by hnRNPA2B1 and Impairs Re-endothelialization After Vascular Injury. Front Cell Dev Biol. 2021; 9:619444. PMC: 8093826. DOI: 10.3389/fcell.2021.619444. View

Makino D, Halbach F, Conti E . The RNA exosome and proteasome: common principles of degradation control. Nat Rev Mol Cell Biol. 2013; 14(10):654-60. DOI: 10.1038/nrm3657. View

Schiffmann L, Plum P, Fuchs H, Babic B, Bruns C, Schmidt T . Tumor Microenvironment of Esophageal Cancer. Cancers (Basel). 2021; 13(18). PMC: 8472305. DOI: 10.3390/cancers13184678. View

Wang Q, Wang Z, Bao Z, Zhang C, Wang Z, Jiang T . relevant bioinformatic profiling and prognostic value in gliomas. Future Oncol. 2019; 16(1):4279-4288. DOI: 10.2217/fon-2019-0268. View

Ma S, Zhang A, Li X, Zhang S, Liu S, Zhao H . MiR-21-5p regulates extracellular matrix degradation and angiogenesis in TMJOA by targeting Spry1. Arthritis Res Ther. 2020; 22(1):99. PMC: 7195789. DOI: 10.1186/s13075-020-2145-y. View

Li S, Xu H, Wu C, Wang W, Jin W, Gao H . Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 2018; 22(1):15-36. DOI: 10.1007/s10456-018-9645-2. View

Dinsart C, Pervolaraki K, Stroh-Dege A, Lavie M, Ronsse I, Rommelaere J . Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle. Hum Gene Ther. 2017; 28(3):295-306. DOI: 10.1089/hum.2016.108. View

10.

Zhang H, Sheng C, Yin Y, Wen S, Yang G, Cheng Z . PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma. Cancer Lett. 2015; 367(1):49-57. DOI: 10.1016/j.canlet.2015.07.010. View

11.

Zhang Y, Chen Y, Yun H, Liu Z, Su M, Lai R . STAT1β enhances STAT1 function by protecting STAT1α from degradation in esophageal squamous cell carcinoma. Cell Death Dis. 2017; 8(10):e3077. PMC: 5682650. DOI: 10.1038/cddis.2017.481. View

12.

Takashima N, Ishiguro H, Kuwabara Y, Kimura M, Haruki N, Ando T . Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. Oncol Rep. 2006; 15(3):667-71. View

13.

Morton D, Kuiper E, Jones S, Leung S, Corbett A, Fasken M . The RNA exosome and RNA exosome-linked disease. RNA. 2017; 24(2):127-142. PMC: 5769741. DOI: 10.1261/rna.064626.117. View

14.

Li S, Xie Y, Zhang W, Gao J, Wang M, Zheng G . Interferon alpha-inducible protein 27 promotes epithelial-mesenchymal transition and induces ovarian tumorigenicity and stemness. J Surg Res. 2014; 193(1):255-64. DOI: 10.1016/j.jss.2014.06.055. View

15.

Chiang K, Huang S, Wu R, Huang S, Yeh T, Chen M . Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival. Cancer Manag Res. 2019; 11:1893-1905. PMC: 6400119. DOI: 10.2147/CMAR.S196485. View

16.

Wu F, Li F, Lin X, Xu F, Cui R, Zhong J . Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Endocr Relat Cancer. 2019; 26(5):525-538. DOI: 10.1530/ERC-19-0008. View

17.

Wang H, Qiu X, Lin S, Chen X, Wang T, Liao T . Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma. World J Surg Oncol. 2018; 16(1):64. PMC: 5870725. DOI: 10.1186/s12957-018-1371-0. View

18.

Liu M, Guo S, Hibbert J, Jain V, Singh N, Wilson N . CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011; 22(3):121-30. PMC: 3203691. DOI: 10.1016/j.cytogfr.2011.06.001. View

19.

Huntzinger E, Braun J, Heimstadt S, Zekri L, Izaurralde E . Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. EMBO J. 2010; 29(24):4146-60. PMC: 3018788. DOI: 10.1038/emboj.2010.274. View

20.

Zhang W, Zhu J, He X, Liu X, Li J, Li W . Exosome complex genes mediate RNA degradation and predict survival in mantle cell lymphoma. Oncol Lett. 2019; 18(5):5119-5128. PMC: 6781731. DOI: 10.3892/ol.2019.10850. View